Literature DB >> 17112815

The 2988G>A polymorphism affects splicing of a CYP2D6 minigene.

Thomas Rau, Silke Diepenbruck, Ines Diepenbruck, Thomas Eschenhagen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17112815     DOI： 10.1016/j.clpt.2006.08.008

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  5 in total

1.  Genetic matters of CYP2D6 in breast cancer: copy number variations and nucleotide polymorphisms.

Authors:  Ke-Da Yu; Zhi-Ming Shao
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

2.  Significantly lower CYP2D6 metabolism measured as the O/N-desmethylvenlafaxine metabolic ratio in carriers of CYP2D6*41 versus CYP2D6*9 or CYP2D6*10: a study on therapeutic drug monitoring data from 1003 genotyped Scandinavian patients.

Authors:  Tore Haslemo; Erik Eliasson; Marin M Jukić; Magnus Ingelman-Sundberg; Espen Molden
Journal:  Br J Clin Pharmacol       Date:  2018-11-11       Impact factor: 4.335

Review 3.  Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.

Authors:  Shu-Feng Zhou
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

4.  Intronic polymorphisms of cytochromes P450.

Authors:  Magnus Ingelman-Sundberg; Sarah C Sim
Journal:  Hum Genomics       Date:  2010-08       Impact factor: 4.639

5.  CYP2D6 gene resequencing in the Malagasy, a population at the crossroads between Asia and Africa: a pilot study.

Authors:  E Ricky Chan; Rajeev K Mehlotra; Karim A Pirani; Arsene C Ratsimbasoa; Scott M Williams; Andrea Gaedigk; Peter A Zimmerman
Journal:  Pharmacogenomics       Date:  2022-03-01       Impact factor: 2.533
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.